It has come to the knowledge, as a part of a major decision the European lawmakers backed new rules for stem cell and other advanced medical therapies here on Wednesday, despite strong opposition from a key member of the European Parliament. It has also been reported, that the European Union legislature had rejected all the ostensible ethical amendments to the regulation that would create a centralised process for approving new tissue and cell engineering therapies in due time.
More »

Celgene Corporation, the renowned integrated global biopharmaceutical company today announced here that human placenta-derived stem cells that are “pluripotent”, or having the ability to become different types of tissue, can be isolated with a proprietary perfusion technology from placentas so they are available for potential treatment applications. The announcement happened in an oral presentation last day at the International Conference on Stem Cells Research and Therapeutics in San Diego by Qian Ye, PhD, the Senior Scientist, at Celgene Cellular Therapeutics.
More »